About
Awards
History
Leadership
Board of Directors
Investors and Partners
Pipeline
Cefepime-Taniborbactam
Ceftibuten-Ledaborbactam Etzadroxil
PBP Inhibitor
Publications
Manuscripts
Conference Presentations
News & Events
Press Releases
In the News
Events
Careers
Open Positions
#venatorxcares
Contact
Publications
Publications
Manuscripts
Conference Presentations
Manuscripts
Impact of porin deletions on cefepime-taniborbactam activity against
Klebsiella pneumoniae
Spectrum of cefepime-taniborbactam coverage against 190 β-lactamases defined in engineered isogenic
Escherichia coli
strains
MORE MANUSCRIPTS
Conference Presentations
Evaluation of Single and Multiple Dose Safety and Pharmacokinetics of Ledaborbactam Etzadroxil and Ceftibuten-Ledaborbactam Etzadroxil in Healthy Volunteers
In vitro activity of ceftibuten-ledaborbactam and comparators against Enterobacterales from a Phase 3 study of adults with complicated urinary tract infection (cUTI)
Outcomes at Test of Cure by baseline pathogen and cefepime-taniborbactam or meropenem MIC in the Phase 3 CERTAIN-1 study of patients with complicated urinary tract infection (cUTI)
In Vitro
Activity of Cefepime-Taniborbactamand Comparator Agents Against Gram-Negative Bacteria Isolated from Patients with Cancer
MORE CONFERENCE PRESENTATIONS
You are using a browser that is not supported. Please consider changing your browser
